Perbedaan Lavender Bina Cendikia Tbk. dan UBC Medical Indonesia Tbk.: Lavender Bina Cendikia Tbk. diperdagangkan di Rp30 (kapitalisasi pasar 30,9 M, volume 24 jam 2,96 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 18,9× kapitalisasi pasar Lavender Bina Cendikia Tbk., dan Lavender Bina Cendikia Tbk. lebih aktif diperdagangkan (2,96 jt vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BMBL | LABS | |
|---|---|---|
Kapitalisasi Pasar | 30,9 M | 584,6 M |
Volume | 2,96 jt | 817,3 rb |
Lot | 29,64 rb | 8,17 rb |
Perputaran | 88,75 jt | 120,01 jt |
Harga Rata-rata | 29,94 | 146,84 |
Nilai Transaksi | 88,75 jt | 120,01 jt |
Harga Ekuilibrium Indikatif | 30 | 146 |
Volume Ekuilibrium Indikatif | 1 | 59 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Lavender Bina Cendikia Tbk ("Company") was established on November 27, 2013 based on theNotarial deed of Suparman Hasyim, S.H., No. 35. The Company started its commercial operations in2013. The ultimate beneficial owner of the Company is Galih Pandekar.
Selengkapnya di halaman BMBL →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →